Skip to main content
TipRanks
Go Ultimate75% OFF

Ampio Pharmaceuticals (AMPE) Ratios

505 Followers

Ampio Pharmaceuticals Ratios

AMPE's free cash flow for Q4 2023 was $-2.31M. For the 2023 fiscal year, AMPE's free cash flow was increased by $0.00 and operating cash flow was $-2.31M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 23Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio2.4111.186.9610.081.93
Quick Ratio2.4111.186.949.941.93
Cash Ratio1.7210.616.629.461.52
Solvency Ratio-3.53-8.50-1.38-2.74-1.64
Operating Cash Flow Ratio-3.60-17.72-2.75-8.03-3.59
Short-Term Operating Cash Flow Coverage0.00-111.79-52.380.00-59.39
Net Current Asset Value$ 3.36M$ 11.53M$ 24.09M$ 13.13M$ 692.00K
Leverage Ratios
Debt-to-Assets Ratio0.050.060.030.050.10
Debt-to-Equity Ratio0.080.070.040.070.23
Debt-to-Capital Ratio0.080.060.040.060.19
Long-Term Debt-to-Capital Ratio0.000.000.000.000.16
Financial Leverage Ratio1.711.151.421.312.17
Debt Service Coverage Ratio0.00-80.89-42.350.00-21.83
Interest Coverage Ratio0.000.000.000.00-241.25
Debt to Market Cap0.000.070.000.000.02
Interest Debt Per Share0.341.441.802.103.26
Net Debt to EBITDA0.460.512.051.110.41
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT90.69%80.15%83.01%100.38%73.37%
Return on Assets (ROA)-150.49%-120.23%-43.98%-69.47%-97.35%
Return on Equity (ROE)-256.90%-138.58%-62.58%-90.76%-211.55%
Return on Capital Employed (ROCE)-283.27%-164.42%-61.04%-75.24%-191.17%
Return on Invested Capital (ROIC)-252.47%-81.73%-43.87%-74.24%-115.63%
Return on Tangible Assets-150.49%-120.23%-43.98%-69.47%-97.35%
Earnings Yield-520.49%-637.62%-15.03%-5.78%-16.53%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.3321.432.566.338.42
Inventory Turnover0.000.0015.194.430.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle-1095.00-17.03-118.4424.79-43.33
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.0024.0282.420.00
Days of Payables Outstanding1095.0017.03142.4657.6343.33
Operating Cycle0.000.0024.0282.420.00
Cash Flow Ratios
Operating Cash Flow Per Share-10.59-37.93-21.21-25.56-32.45
Free Cash Flow Per Share-10.59-37.93-21.35-25.67-32.50
Dividend Paid and CapEx Coverage Ratio0.000.00-145.25-233.79-699.23
Capital Expenditure Coverage Ratio0.000.00-145.25-233.79-699.23
Operating Cash Flow Coverage Ratio-31.26-26.31-11.80-12.18-10.47
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-516.39%-824.60%-12.49%-5.38%-18.68%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.19-0.16-6.65-17.29-6.05
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio0.490.224.1615.6912.80
Price-to-Free Cash Flow (P/FCF) Ratio-0.19-0.12-8.01-18.58-5.35
Price-to-Operating Cash Flow Ratio-0.19-0.12-8.06-18.66-5.36
Price-to-Earnings Growth (PEG) Ratio0.040.000.19-0.310.05
Enterprise Value Multiple0.260.40-5.06-17.74-6.30
Enterprise Value-2.16M-9.29M80.90M258.69M77.42M
EV to EBITDA0.260.40-5.06-17.74-6.30
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow0.250.44-5.70-17.49-5.03
EV to Operating Cash Flow0.250.44-5.74-17.56-5.03
Tangible Book Value Per Share4.1521.1741.0730.3913.59
Shareholders’ Equity Per Share4.1521.1741.0730.3913.59
Tax and Other Ratios
Effective Tax Rate0.000.480.27-0.040.36
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-10.67-29.33-25.70-27.59-28.75
Tax Burden1.001.001.001.001.00
Interest Burden1.000.671.001.001.01
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.991.290.830.931.13

Currency in USD